US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Laboratory Corp American Holdings (NY:LH)

308.65 +0.16 (+0.05%)
Official Closing Price Updated: 7:00 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Laboratory Corp American Holdings

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
3 Low-Volatility Stocks That Concern Us
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. Luckily for ... 
Via StockStory
News headline image
Why Labcorp Holdings Stock Dropped Today ↗
The government thinks it's been overpaying Labcorp. They plan to stop doing that next year. 
Via The Motley Fool
Topics Regulatory Compliance
Discover the top S&P500 movers in Tuesday's pre-market session. ↗
Via Chartmill
News headline image
1 Mid-Cap Stock with Competitive Advantages and 2 That Underwhelm
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. Howe... 
Via StockStory
Labcorp (NYSE:LH) Shares Slide on Q2 Revenue Miss Despite Earnings Beat ↗
Via Chartmill
News headline image
1 Profitable Stock Worth Your Attention and 2 Facing Headwinds
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
3 Reasons LH is Risky and 1 Stock to Buy Instead
Over the past six months, Labcorp has been a great trade, beating the S&P 500 by 9.5%. Its stock price has climbed to $339.34, representing a healthy 20% inc... 
Via StockStory
Topics Stocks
News headline image
Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million ↗
Schechter maintains a $33 million stake after this pre-scheduled sale under a Rule 10b5-1 plan. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
5 Revealing Analyst Questions From Labcorp’s Q2 Earnings Call
Labcorp’s second quarter results were well received by the market, as the company delivered solid revenue growth and exceeded Wall Street’s non-GAAP profit e... 
Via StockStory
Topics Earnings
Wondering what's happening in today's S&P500 pre-market session? ↗
Via Chartmill
News headline image
Labcorp (LH) Q2 2026 Earnings Call Transcript ↗
Specialty testing and Central Labs fueled revenue growth and margin expansion. 
Via The Motley Fool
Topics Earnings Retirement
News headline image
Labcorp Q2 Earnings Call Highlights ↗
Labcorp (NYSE:LH) reported second-quarter 2026 revenue growth, margin expansion and higher adjusted earnings, prompting the laboratory services company to raise the midpoint of its full-year revenue... 
Via MarketBeat
Topics ETFs Earnings
News headline image
LH Q2 Deep Dive: Specialty Testing and Consumer Growth Drive Guidance Increase
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $3.73 billi... 
Via StockStory
News headline image
Labcorp (LH) Q2 2026 Earnings Call Transcript ↗
Specialty testing and Central Labs fueled revenue growth and margin expansion. 
Via The Motley Fool
Topics Earnings Retirement
Top S&P500 movers in Thursday's pre-market session ↗
Via Chartmill
News headline image
Labcorp (NYSE:LH) Reports Q2 CY2026 In Line With Expectations
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $3.73 billi... 
Via StockStory
News headline image
What To Expect From Labcorp’s (LH) Q2 Earnings
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be announcing earnings results this Thursday before market hours. Here’s what to look for. Lab... 
Via StockStory
News headline image
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as... 
Via StockStory
News headline image
3 Mid-Cap Stocks Walking a Fine Line
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to beco... 
Via StockStory
News headline image
3 Reasons LH is Risky and 1 Stock to Buy Instead
Labcorp currently trades at $265.08 per share and has shown little upside over the past six months, posting a middling return of 4.4%. Is now the time to buy... 
Via StockStory
News headline image
Q1 Earnings Highlights: Labcorp (NYSE:LH) Vs The Rest Of The Testing & Diagnostics Services Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
Via StockStory
News headline image
2 S&P 500 Stocks for Long-Term Investors and 1 Facing Challenges
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
Via StockStory
Topics Credit Cards Stocks
Top S&P500 movers in Friday's pre-market session ↗
Via Chartmill
News headline image
3 Cash-Producing Stocks That Concern Us
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
Topics Economy
News headline image
3 Profitable Stocks We Find Risky
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi... 
Via StockStory
News headline image
3 Healthcare Stocks We Steer Clear Of
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recentl... 
Via StockStory
Topics Economy
News headline image
The 5 Most Interesting Analyst Questions From Labcorp’s Q1 Earnings Call
Labcorp’s first quarter was marked by continued growth in both its Diagnostics and Biopharma Laboratory Services businesses, supported by strategic partnersh... 
Via StockStory
Topics Earnings Fraud
News headline image
1 of Wall Street’s Favorite Stock with Competitive Advantages and 2 We Turn Down
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
Topics Electric Vehicles
News headline image
LH Q1 Deep Dive: Specialty Testing and Acquisitions Drive Growth Amid Margin Expansion
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 5.8% year on year to $3.54 bill... 
Via StockStory
Topics Artificial Intelligence
News headline image
Labcorp (LH) Q1 2026 Earnings Call Transcript ↗
Labcorp (LH) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings Retirement
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >